BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Algashaamy K, Garcia-Buitrago M. Multifocal G1-G2 gastric neuroendocrine tumors: Differentiating between Type I, II and III, a clinicopathologic review. World J Clin Cases 2019; 7(17): 2413-2419 [PMID: 31559277 DOI: 10.12998/wjcc.v7.i17.2413]
URL: https://www.wjgnet.com/2307-8960/full/v7/i17/2413.htm
Number Citing Articles
1
L.E. Gurevich, O.A. Vasyukova, L.M. Mikhaleva, E.V. Bondarenko, V.E. Shikina. Characteristics of gastric neuroendocrine tumors and the PDX-1 transcription factor expressionRussian Journal of Archive of Patology 2024; 86(3): 12 doi: 10.17116/patol20248603112
2
Ming Shi, Zhiyao Fan, Jianwei Xu, Jian Yang, Yongzheng Li, Changhao Gao, Peng Su, Xiao Wang, Hanxiang Zhan. Gastroenteropancreatic neuroendocrine neoplasms G3: Novel insights and unmet needsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021; 1876(2): 188637 doi: 10.1016/j.bbcan.2021.188637
3
Raffaella Magris, Valli De Re, Stefania Maiero, Mara Fornasarig, Giovanni Guarnieri, Laura Caggiari, Cinzia Mazzon, Giorgio Zanette, Agostino Steffan, Vincenzo Canzonieri, Renato Cannizzaro. Low Pepsinogen I/II Ratio and High Gastrin-17 Levels Typify Chronic Atrophic Autoimmune Gastritis Patients With Gastric Neuroendocrine TumorsClinical and Translational Gastroenterology 2020; 11(9): e00238 doi: 10.14309/ctg.0000000000000238
4
Ying-Ying Chen, Wen-Juan Guo, Yan-Fen Shi, Fei Su, Fu-Huan Yu, Ru-Ao Chen, Chao Wang, Ji-Xi Liu, Jie Luo, Huang-Ying Tan. Management of type 1 gastric neuroendocrine tumors: an 11-year retrospective single-center studyBMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-03079-6
5
Xiu-Zhen Ma, Ni Zhou, Xiu Luo, Si-Qi Guo, Ping Mai. Update understanding on diagnosis and histopathological examination of atrophic gastritis: A reviewWorld Journal of Gastrointestinal Oncology 2024; 16(10): 4080-4091 doi: 10.4251/wjgo.v16.i10.4080